physical

New research suggests that people with obesity who take GLP-1 drugs appear to scale back on physical activity once they start taking the drug. A study presented on June 14 at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, had researchers use data from the National Institutes of Health’s All of Us Research Program, which…